Biochem/physiol Actions
α-adrenoceptor antagonist; peripheral vasodilator.
Features and Benefits
This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Packaging
100, 500 mg in glass bottle
Storage and Stability
Protect From Light.
This product has met the following criteria to qualify for the following awards: